Diurnal variations of extrapyramidal symptoms induced by haloperidol in schizophrenic subjects

International Journal of Neuropsychopharmacology

Volumn 6, Issue 3, 2003, Pages 243-246

  Torner, Carlos ^a,b   Herrera Estrella, Miguel ^b   Gutiérrez, José A ^b   Aguilar Roblero, Raul ^c  

^a DEPARTAMENTO DE SISTEMAS BIOLÓGICOS   (Mexico)

^b HOSPITAL PSIQUIÁTRICO FRAY BERNARDINO ÁLVAREZ   (Mexico)

^c UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Akathisia (drug induced); Antipsychotic agents (adverse effects); Circadian rhythms; Dopamine receptors; Extrapyramidal tracts (drug effects); Schizophrenia

Indexed keywords

DOPAMINE 2 RECEPTOR; HALOPERIDOL;

ADULT; AKATHISIA; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOPAMINERGIC TRANSMISSION; DRUG MECHANISM; DRUG RECEPTOR BINDING; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; SCHIZOPHRENIA; SIDE EFFECT;

ADULT; AKATHISIA, DRUG-INDUCED; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; CIRCADIAN RHYTHM; CROSS-SECTIONAL STUDIES; DYSTONIA; HALOPERIDOL; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0141892734     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1461145703003511     Document Type: Article

References (24)

1. APA (1994). Manual diagnóstico y estadístico de los trastornos mentales (DSM-IV). Barcelona, Edit. Masson: American Psychiatric Association.
2. Dávila R, Zumárraga M, Andia I, Friedhoff AJ (1989). Persistence of cyclicity of the plasma dopamine metabolite, homovanillic acid, in neuroleptic treated schizophrenic patients. Life Sciences 44, 1117-1121.
3. DiMascio A, Bernardo DL, Greenblat DJ, Marder JE (1976). A controlled trial of amantadine in drug-induced extrapyramidal disorders. Archives of General Psychiatry 33, 599-602.
4. DiMascio A, Shader RI (1969). Drug administration schedules. American Journal of Psychiatry 126, 796-801.
5. Hyde TM, Egan MF, Brown RJ, Weinberger DR, Kleinman JE (1995). Diurnal variations in tardive dyskinesia. Psychiatry Research 56, 53-57.
6. Kafka MS, Wirz-Justice A, Naber D, Moore RY, Benedito MA (1982). Circadian rhythms in rat brain neurotransmitter receptors. Federation Proceedings 42, 2796-2801.
7. Lee JH, Branchey M, Haher J, Varga E, Simpson GM (1974). Once versus thrice daily thiothixene in the treatment of schizophrenic in-patients. British Journal of Psychiatry 125, 73-78.
8. Linazasoro G, Marti-Masso JF, Suarez JA (1993). Nocturnal akathisia in Parkinson's disease: treatment with clozapine. Movement Disorders 8, 171-174.
9. Mao CC, Cheney DL, Marco E, Revuelta A, Costa E (1977). Turnover times of gamma-aminobutyric acid and acetylcholine in nucleus caudatus, nucleus accumbens, globus pallidus and substantia nigra: effects of repeated administration of haloperidol. Brain Research 132, 375-379.
10. Mazurek MF, Rosebush PI (1996). Circadian pattern of acute, neuroleptic-induced dystonic reactions. American Journal of Psychiatry 153, 708-710.
11. Meltzer HY, Nash F (1991). VII. Effects of antipsychotic drugs on serotonin receptors. Pharmacological Reviews 43, 587-761.
12. Nagayama H, Takagi A, Takahashi R (1981). Chronopharmacological studies of neuroleptics. In: Saletu B, Berner P, Hollister L (Eds.), Current Developments in Psychopharmacology vol. 6 (pp. 191-214). New York: Spectrum.
13. Nutt JG, Carter JH, Lea ES, Woodward WR (1997). Motor fluctuation during continuous levodopa infusions in patients with Parkinson's disease. Movement Disorders 12, 285-292.
14. Ortega-Soto H, Jasso A, Ceceña G, Hernández C (1991). La validez y la reproducibilidad de dos escalas para evaluar los síntomas extrapiramidales inducidos por neurolépticos. Salud Mental 14, 1-5.
15. Pazo JH, Rascovsky S, Jerusalinsky D, Medina JH, Tumilasci OR (1989). Increase of muscarinic cholinergic receptors in the rat submandibular glands after parasympathectomy and repeated administration of haloperidol. General Pharmacology 20, 759-761.
16. Reinberg AE (1992). Concepts in chronopharmacology. Annual Review of Pharmacology and Toxicology 32, 51-66.
17. Sack DA, James SP, Doran AR, Sherer MA, Linnoila M, Wehr TA (1988). The diurnal variation in plasma homovanillic acid level persists but the variation in 3-methoxy-4-hydroxyphenylglycol level is abolished under constant conditions. Archives of General Psychiatry 45, 162-166.
18. 2 receptors in different brain regions of the rat. Biological Rhythm Research 32, 363-372.
19. 2 dopaminergic receptors and its relation with haloperidol-induced catalepsy. Biological Rhythm Research 29, 538-545.
20. Uriarte V, Rüther E (1976). Diferencias psicopatológicas entre dos esquemas de tratamiento con un neuroléptico (haloperidol). Psiquiatría 6, 3-6.
21. Wirz-Justice A (1986). Circadian rhythms of receptors. Chronobiology International (Special Issue) 3, 87-146.
22. Yamazumi S, Miura S (1981). Haloperidol concentrations in saliva and serum: determination by the radioimmunoassay method. International Pharmacopsychiatry 16, 174-183.
23. Zimmerman TR, Sage JI, Lang AE, Mark MH (1994). Severe evening dyskinesias in advanced Parkinson's disease: clinical description, relation to plasma levodopa, and treatment. Movement Disorders 9, 173-177.
24. Zumárraga M, Andía I, Bárcena B, González-Torres MA, Dávila R (1993). Morning variations of plasma homovanillic acid in untreated schizophrenic patients. Journal of Psychiatry Research 27, 11-16.